Berberine ursodeoxycholate

Star0

DB18111InvestigationalSmall molecule

Berberine ursodeoxycholate: Overview.

Formula / weight: C₄₄H₅₇NO₈ · 727.939 g/mol (avg)
Also known as: 9,10-dimethoxy-5,6-dihydro-2H,8H-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-8-ylium 3α,7β-dihydroxy-5β-cholan-24-oate · Cholan-24-oic acid, 3,7-dihydroxy-, ion(1-), (3α,5β,7β)-, 5,6-dihydro-9,10-dimethoxybenzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium (1:1)
Code names: HTD1801

Resolves to

Compound

UNIIVM8KQ3W8GMCAS1868138-66-2

Structure

InChIKeyFHZVFXJRSFLYDY-FUXQPCDDSA-MSMILES

COC1=C(OC)C2=C[N+]3=C(C=C2C=C1)C1=CC2=C(OCO2)C=C1CC3.[H][C@@]12CC[C@H]([C@H](C)CCC([O-])=O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])[C@@H](O)C[C@]2([H])C[C@H](O)CC[C@]12C

What you can answer from here — as of December 10, 2025

10Clinical trialsPhase, status and sponsor resolved per trial

Which companies are running trials of Berberine ursodeoxycholate, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account